Schizophrenia Linked to Higher COVID-19 Mortality
Individuals diagnosed with mood or anxiety disorders were not linked to higher COVID-19 mortality.
COVID-19 Only Adding to the Challenges Health Centers Face
National Health Center Week kicks off on August 9.
Psychedelic Drug Reduces Anxiety, Depressive Symptoms in Cancer Patients
Psilocybin, which is commonly found in psychedelic mushrooms, is linked with enduring antianxiety and antidepressant effects.
Arjun Masurkar, MD, PhD: Clinical Trials for Alzheimer Disease
Arjun Masurkar, MD, PhD, discusses some of the issues with Alzheimer disease clinical trials.
Arjun Masurkar, MD, PhD: Genetic Testing for Alzheimer Disease
Arjun Masurkar, MD, PhD, discusses how genetic testing could usher in a new wave of diagnostics for Alzheimer disease.
Lenard Adler, MD: Improvements in ADHD Screening
Lenard Adler, MD, talks about some of the advances in recent years in screening for ADHD in adults and adolescents.
Shaline Rao, MD: Causes of Rising Heart Failure Rates
A discussion on why heart failure rates have climbed over the past decade while research indicates rates of cardiovascular disease, as a whole, have begun to decline.
Margaret Nachtigall, MD: Big Picture OB/GYN Care
How women's health burdens touch genetics, psychiatry, cardiology, and whether physicians are equipped to manage it all.
Jeffrey Berger, MD: Key Differences in ISCHEMIA and ISCHEMIA-CKD Results
Discussing the key differences in the results of ISCHEMIA and ISCHEMIA-CKD, which examined whether the use of invasive or conservative strategies was more effective for patients with ischemic heart disease.
Purvi Parikh, MD: The State of Food Allergy Care
In months, the US may have its first marketed peanut immunotherapies. How will pediatric patient management change?
Akankasha Goyal, MD: Effectiveness of Fight Against Diabetes
Discussing why initiatives and policy changes in the fight against obesity and diabetes have been perceived as less successful than those against smoking and educating on cardiovascular diseases.
Charles Marmar, MD: The Differences in PTSD Treatment
How PTSD care can be, and should be, individualized for particular patient needs.
Shaline Rao, MD: Dapagliflozin and The Role of SGLT2 Inhibitors
Evaluating the impact of DAPA-HF and other recent data that have changed the way cardiologists view the potential uses of SGLT2 inhibitors in patients with or without diabetes.
Jeffrey Berger, MD: Evolving Role of Aspirin
Discussing how new information released in 2019 has impacted the way cardiologists view aspirin use for primary and secondary prevention of cardiovascular events.
Arjun Masurkar, MD, PhD: New Treatment on the Horizon for Alzheimer Disease
Arjun Masurkar, MD, PhD, previews some of the new medications that could help treat Alzheimer disease, while reviewing some of the advancements of the last decade.
Margaret Nachtigall, MD: Managing Menopause
Patient demographics influence difference symptoms, progression, and benefits of care.
Purvi Parikh, MD: Pediatric Asthma Care with Biologics
How to weigh the 5 agents from the drug class, which have each shown differing benefit in younger patients.
USPSTF: Inconclusive Evidence for Lead Screening in Asymptomatic Children
A task force found insufficient evidence on the benefits and harms of screening for lead in asymptomatic children and pregnant persons.
Short Stays in Skilled Nursing Facilities Linked to High Readmission Rates
Investigators found readmission risk was 4 times greater in patients with stays of 2 days or less.
Chirag Barbhaiya, MD: The Average Afib Patient
As Americans population ages, yet becomes more health conscious, has the average patient suffering from Afib changed in recent years?
Jeffrey Berger, MD: When to use GLP1 Agonists or SGLT2 Inhibitors
How and when do you decide whether to prescribe a patient GLP1 agonists or SGLT2 inhibitors?
Charla Fischer, MD: Discussing the Future of Orthopedics
How has technology changed the way orthopedic specialists practice and what is driving advances such as minimally invasive spine surgery?
Jeffrey Berger, MD: Future of Heart Health
What are some of the future risks, in terms of cardiovascular health, facing the average patient?
Jeffrey Berger, MD: Impact of Updated Aspirin Guidelines
Insight regarding the recent change to aspirin guidelines and what it means for patients from platelet specialist Jeffrey Berger, MD.
Chirag Barbhaiya, MD: How Ablation Success Rates are Misleading
Barbhaiya talks about what he considers to be misleading success rates for Afib ablation being published in studies.
Chirag Barbhaiya, MD: Apple Heart Study Reaction
Discussing the implications and future of wearable technology after the release of the Apple Heart Study.
Charla Fischer, MD: Orthopedic Patients Going Forward
What sort of problems will orthopedic surgeons face in the future and how has the average patient changed in recent years?
Chirag Barbhaiya, MD: Updated Afib Guidelines
MD Magazine sat down with Chirag Barbhaiya, MD, of NYU Langone Health, to discuss the updated guidelines for treating a patient with Afib.
Transcranial Stimulation at Home Reduces Fatigue in Multiple Sclerosis
A sham-controlled trial demonstrated that a novel at-home administration of transcranial stimulation reduced fatigue in multiple sclerosis.
James Underberg, MD: Statin Intolerance, Drug Costs in Cardiovascular Care
The seemingly complicated maneuvers of getting patient’s cholesterol better can be resolved with common sense. What’s best for the patient?
